A tighter archive for life-science signals.
Search once, then narrow by source or topic.
<a href="https://www.fiercebiotech.com/biotech/pfizer-details-phase-3-data-mrna-flu-vaccine" hreflang="en">Pfizer's mRNA flu vaccine shows 34.5% greater efficacy than standard shot in phase 3</a>
Pfizer has released the full data from its phase 3 trial of an mRNA flu vaccine candidate, with the potential new shot securing 34.5% greater effectiveness compared to...
Illumina whole-genome sequencing provides greater insight into genetic signals behind common diseases--according to Nature study - PR Newswire
Illumina whole-genome sequencing provides greater insight into genetic signals behind common diseases--according to Nature study PR Newswire
Here's Why Lonza Group (LZAGY) Is a Great 'Buy the Bottom' Stock Now - Nasdaq
Here's Why Lonza Group (LZAGY) Is a Great 'Buy the Bottom' Stock Now Nasdaq
Here's Why Lonza Group (LZAGY) Is a Great 'Buy the Bottom' Stock Now - Yahoo Finance
Here's Why Lonza Group (LZAGY) Is a Great 'Buy the Bottom' Stock Now Yahoo Finance
Illumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development - PR Newswire
Illumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development PR Newswire
Lonza Group Ag (LZAGY) is a Great Momentum Stock: Should You Buy? - Nasdaq
Lonza Group Ag (LZAGY) is a Great Momentum Stock: Should You Buy? Nasdaq
Cytiva’s strategic expansion in Western Switzerland’s Health Valley - Greater Geneva Bern area
Cytiva’s strategic expansion in Western Switzerland’s Health Valley Greater Geneva Bern area
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page